A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

NCT02779751 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Breast Cancer

Interventions

DRUG: Abemaciclib
DRUG: Pembrolizumab
DRUG: Anastrozole

Sponsor

Eli Lilly and Company

Collaborators

Merck Sharp & Dohme LLC